Report #2892253

Received Apr 9, 2026

Office visit

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 11 yrs
State: IL
Recovered: Recovered
Vaccinated: Mar 31, 2026
Onset: Apr 2, 2026
Days to onset: 2
Hospital days: —

Vaccines (3)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	1	Z002437	IM / LA
MNQ	MENINGOCOCCAL CONJUGATE (MENVEO)	NOVARTIS VACCINES AND DIAGNOSTICS	1	LL347	IM / RA
TDAP	TDAP (BOOSTRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	4YA34	IM / RA

Symptoms (1)

Injection site urticaria

Symptom narrative

Localized urticarial reaction following recent Tdap and meningococcal vaccination. Symptoms mild and limited to injection site. No evidence of systemic allergic reaction or anaphylaxis. In-office interventions-Ice pack applied to right upper arm for 15 minutes with improvement in discomfort. Injection site cleansed with alcohol wipes. Topical hydrocortisone and diphenhydramine cream applied, covered with 4x4 gauze and Tegaderm dressing. Loratadine 10 mL administered in office x 1 dose. Discussed alarm signs and symptoms of anaphylactic reaction. Continue cool compresses as needed. Avoid scratching.

Current illness

none

Medical history

moderate persistent asthma

Other medications

albuterol HFA 108 (90 Base) MCG/ACT IN inhaler Dose: 2 puff Route: Inhalation Frequency: Every 6 hours PRN for wheezing, shortness of breath, mometasone-formoterol (DULERA 100) 100-5 MCG/ACT inhaler Dose: 2 puff Route: Inhalation Frequen

Allergies

No known food or drug allergies

Lab data

N/A